SI
NVO

Sofinnova Investments’s Novo Nordisk NVO Stock Holding History

Sofinnova Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-726,329
Closed -$86.5M – 71
2024
Q3 		$86.5M Buy
726,329
+76,788
+12% +$10.2M 6.86% 3
2024
Q2 		$92.7M Buy
649,541
+37,657
+6% +$4.99M 4.82% 5
2024
Q1 		$78.6M Buy
+611,884
New +$72.8M 4.38% 7
2022
Q3 		– Sell
-547,746
Closed -$30.5M – 62
2022
Q2 		$30.5M Buy
+547,746
New +$30.4M 2.54% 10
2019
Q3 		– Sell
-647,394
Closed -$16.5M – 80
2019
Q2 		$16.5M Buy
647,394
+151,926
+31% +$3.75M 1.52% 16
2019
Q1 		$13M Buy
+495,468
New +$12.2M 1.25% 17

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sofinnova Investments's NVO Position: Q4 2024 in Review

Sofinnova Investments sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 726,329 shares — an estimated $86.5M sold.

Sofinnova Investments first reported a position in NVO in Q1 2019 and held it in 6 quarters. The position peaked at $92.7M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sofinnova Investments reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Sofinnova Investments sold 726,329 Novo Nordisk shares in Q4 2024, an estimated $86.5M.
  • Sofinnova Investments first reported a position in Novo Nordisk in Q1 2019 and held it in 6 quarters.
  • Sofinnova Investments's Novo Nordisk position peaked at $92.7M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sofinnova Investments's 13F filing for Q4 2024, filed 14 Feb 2025.